AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $14,000 | +55.6% | 4,608 | -20.5% | 0.00% | – |
| Q2 2016 | $9,000 | -80.0% | 5,797 | -52.1% | 0.00% | – |
| Q1 2016 | $45,000 | -60.5% | 12,103 | +7.4% | 0.00% | – |
| Q4 2015 | $114,000 | -50.6% | 11,266 | -33.7% | 0.00% | – |
| Q3 2015 | $231,000 | -28.3% | 16,993 | +0.0% | 0.00% | – |
| Q2 2015 | $322,000 | -33.6% | 16,991 | -8.3% | 0.00% | – |
| Q1 2015 | $485,000 | +47.0% | 18,522 | +17.6% | 0.00% | – |
| Q4 2014 | $330,000 | -91.2% | 15,745 | -85.9% | 0.00% | -100.0% |
| Q3 2014 | $3,734,000 | +92.8% | 111,878 | +85.4% | 0.00% | +100.0% |
| Q2 2014 | $1,937,000 | -85.7% | 60,350 | -79.5% | 0.00% | -84.6% |
| Q1 2014 | $13,577,000 | -31.9% | 293,992 | +4.7% | 0.01% | -31.6% |
| Q4 2013 | $19,924,000 | -38.7% | 280,771 | -25.9% | 0.02% | -42.4% |
| Q3 2013 | $32,513,000 | +3231.2% | 379,164 | +2360.7% | 0.03% | +3200.0% |
| Q2 2013 | $976,000 | – | 15,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 372,001 | $7,790,000 | 6.22% |
| Broadfin Capital, LLC | 5,097,726 | $106,746,000 | 4.64% |
| ARMISTICE CAPITAL, LLC | 372,000 | $7,790,000 | 3.74% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $112,026,000 | 2.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,350,000 | 0.57% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,755,933 | $57,709,000 | 0.34% |
| NORTH TIDE CAPITAL, LLC | 200,000 | $4,188,000 | 0.28% |
| Broadfin Capital, LLC | 300,000 | $6,282,000 | 0.27% |
| Point72 Asset Management, L.P. | 1,854,600 | $38,835,000 | 0.27% |
| PointState Capital LP | 600,000 | $12,564,000 | 0.21% |